Orion Infusions (DHA:ORIONINFU) EV-to-EBIT : 83.83 (As of Jul. 24, 2025)

Orion Infusions EV-to-EBIT Chart

Orion Infusions Annual Data
	Trend	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24
EV-to-EBIT		Get a 7-Day Free Trial					23.04	20.68	21.88	89.93	118.35

Orion Infusions Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															129.07	118.35	89.25	102.82	96.79

Competitive Comparison of Orion Infusions's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Infusions's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Orion Infusions's EV-to-EBIT falls into.

Orion Infusions EV-to-EBIT Calculation

Orion Infusions's EV-to-EBIT for today is calculated as:

Orion Infusions's current Enterprise Value is BDT7,160.9 Mil.
Orion Infusions's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT85.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Infusions  (DHA:ORIONINFU) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Orion Infusions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Orion Infusions's Enterprise Value for the quarter that ended in Mar. 2025 was BDT8,268.5 Mil.
Orion Infusions's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT85.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Infusions EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Orion Infusions's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions Business Description